![]() |
|
|


Cargill Health and Food Technologies, Wayzata, MN 55391;
*
Center for Health and Disease Research, Department of Health and Clinical Sciences, University of Massachusetts-Lowell, Lowell, MA 01854; and
Cargill Sweeteners North America, Dayton, OH 45414-4321
2To whom correspondence should be addressed. E-mail: Robert_Nicolosi{at}uml.edu.
The cholesterol-lowering activities of oats and barley are commonly attributed to the ß-glucan fractions. Although ß-glucan is present in both grains and appears to be chemically similar, the effect of source on cholesterol-lowering activity has not been evaluated. In the present study, the antiatherogenic properties of ß-glucan concentrates from oats and barley were evaluated in Syrian golden F1B hamsters consuming a semipurified hypercholesterolemic diet (HCD) containing cholesterol (0.15 g/100 g), hydrogenated coconut oil (20 g/100 g) and cellulose (15 g/100 g). After a 2-wk lead-in period, control hamsters were fed the HCD, whereas experimental hamsters consumed HCD formulated to include ß-glucan (2, 4, or 8 g/100 g) by addition of ß-glucan concentrate prepared from oats or barley at the expense of cellulose. Compared with control hamsters, dose-dependent decreases that were similar in magnitude in plasma total and LDL cholesterol concentrations were observed in hamsters fed ß-glucan from either source at wk 3, 6 and 9. Compared with controls, liver cholesterol concentrations were also reduced (P < 0.05) in hamsters consuming 8 g/100 g oat or barley ß-glucan. In agreement with previously proposed mechanisms, total fecal neutral sterol concentrations were significantly increased (P < 0.05) in hamsters consuming 8 g/100 g barley or oat ß-glucan. Aortic cholesterol ester concentrations were significantly reduced (P < 0.05) in hamsters fed 8 g/100 g ß-glucan from barley or oats. Although aortic total cholesterol and cholesterol ester concentrations were significantly correlated with LDL cholesterol (r = 0.565, P < 0.004 and r = 0.706, P < 0.0001, respectively), this association could explain only half of the variability. This study demonstrated that the cholesterol-lowering potency of ß-glucan is approximately identical whether its origin was oats or barley.
KEY WORDS: ß-glucan LDL cholesterol fecal neutral sterol aortic cholesterol ester early atherosclerosis
This article has been cited by other articles:
![]() |
A. Hang, D. Obert, A. I. N. Gironella, and C. S. Burton Barley Amylose and {beta}-Glucan: Their Relationships to Protein, Agronomic Traits, and Environmental Factors Crop Sci., July 30, 2007; 47(4): 1754 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Park, H. W. Kim, S. H. Ko, J. H. Lim, G. R. Ryu, H. W. Chung, S. W. Han, S. J. Shin, B. K. Bang, M. D. Breyer, et al. Long-Term Treatment of Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Diabetic Nephropathy through Improving Metabolic Anomalies in db/db Mice J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1227 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wilson, R. J. Nicolosi, B. Delaney, K. Chadwell, V. Moolchandani, T. Kotyla, S. Ponduru, G.-H. Zheng, R. Hess, N. Knutson, et al. Reduced and High Molecular Weight Barley {beta}-Glucans Decrease Plasma Total and Non-HDL-Cholesterol in Hypercholesterolemic Syrian Golden Hamsters J. Nutr., October 1, 2004; 134(10): 2617 - 2622. [Abstract] [Full Text] [PDF] |
||||